Lpath Puts the Brakes on Two Ophthalmology Trials due to Manufacturing Issues – Genetic Engineering News
January 27th, 2012
Lpath Puts the Brakes on Two Ophthalmology Trials due to Manufacturing IssuesGenetic Engineering NewsThe Phase II studies included Nexus in wet age-related macular degeneration (AMD) and PEDigree in retinal pigmented epithelial (RPE) detachment. Both were at the patient-dosing stage. FDA found that the company's fill/finish contractor, Formatech, …and more »
Original post by macular degeneration – Google News
(click on the author/publication link above to see full post)